Laser Acupuncture in Egyptian Systemic Lupus Females With Insulin Resistance

Last updated: November 20, 2022
Sponsor: Cairo University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes And Hypertension

Diabetes (Pediatric)

Musculoskeletal Diseases

Treatment

N/A

Clinical Study ID

NCT05632029
P.T.REC/012/004113
  • Ages 18-50
  • Female

Study Summary

glucose hemosatasis, oxidative stress, abnormalities of blood pressures, and high inflammatory status is high presented in lupus patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • prediabetic lupus females (n =64)

Exclusion

Exclusion Criteria:

  • obesity diabetes heart or respiratory problems

Study Design

Total Participants: 64
Study Start date:
October 20, 2022
Estimated Completion Date:
March 30, 2023

Study Description

64 lupus prediabetic women will equally distributed to group A (n =32 that will receive laser acupuncture (active) for one month (3 days week) on acupoint number 14 of GV meridian, acupoint number 4 and 11 of large intestine, acupoint number 34 of gall bladder meridian, acupoint number 3 of liver meridian, acupoint number 4, 12, and 9 of conception vessel meridian, acupoint number 40, 36, and 25 of stomach meridian, acupoint number 6 of spleen meridian, and acupoint number 5 of triple energizer meridian, laser will be applied for 1 min on every acupiont) or group B (n =32 this group will receive the same protocol of group A but the points will be sham points)

Connect with a study center

  • Cairo Unoversity

    Giza,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.